Home LiteratureArticle Details
PMID: 26853747 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer.

Cell metabolism ·Vol. 23 ·No. 3 ·2016-03-08 ·Pages 517-28

Davidson SM, Papagiannakopoulos T, Olenchock BA, Heyman JE, Keibler MA, Luengo A, Bauer MR, Jha AK, O'Brien JP, Pierce KA, Gui DY, Sullivan LB, Wasylenko TM, Subbaraj L, Chin CR, Stephanopolous G, Mott BT, Jacks T, Clish CB, Vander Heiden MG

Abstract

Cultured cells convert glucose to lactate, and glutamine is the major source of tricarboxylic acid (TCA)-cycle carbon, but whether the same metabolic phenotype is found in tumors is less studied. We infused mice with lung cancers with isotope-labeled glucose or glutamine and compared the fate of these nutrients in tumor and normal tissue. As expected, lung tumors exhibit increased lactate production from glucose. However, glutamine utilization by both lung tumors and normal lung was minimal, with lung tumors showing increased glucose contribution to the TCA cycle relative to normal lung tissue. Deletion of enzymes involved in glucose oxidation demonstrates that glucose carbon contribution to the TCA cycle is required for tumor formation. These data suggest that understanding nutrient utilization by tumors can predict metabolic dependencies of cancers in vivo. Furthermore, these data argue that the in vivo environment is an important determinant of the metabolic phenotype of cancer cells.

MeSH Terms
Animals Blood Glucose Carcinoma, Non-Small-Cell Lung/genetics,metabolism,pathology Cell Line, Tumor Glucose/metabolism Humans Lung/metabolism,pathology Lung Neoplasms/genetics,metabolism,pathology Mice, 129 Strain Mice, Inbred C57BL Mice, Nude Mitochondria/metabolism Mutation, Missense Neoplasm Transplantation Proto-Oncogene Proteins p21(ras)/genetics Pyruvic Acid/metabolism Tumor Microenvironment
Chemicals
Blood Glucose KRAS protein, human Pyruvic Acid Proto-Oncogene Proteins p21(ras) Glucose
Authors & Affiliations
20 authors, click to expand affiliations / ORCID
Davidson Shawn M
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA.
Papagiannakopoulos Thales
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Olenchock Benjamin A
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Heyman Julia E
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Keibler Mark A
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Luengo Alba
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Bauer Matthew R
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Jha Abhishek K
Elucidata Corporation, Cambridge, MA 02139, USA.
O'Brien James P
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Pierce Kerry A
Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA.
Gui Dan Y
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Sullivan Lucas B
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Wasylenko Thomas M
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Subbaraj Lakshmipriya
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Chin Christopher R
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Stephanopolous Gregory
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Mott Bryan T
National Center for Advancing Translational Sciences, NIH, Bethesda, MD 20892, USA.
Jacks Tyler
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Clish Clary B
Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA.
Vander Heiden Matthew G
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: mvh@mit.edu.
References (46)
46 references, click to expand
  1. Role of glutamine in human carbohydrate metabolism in kidney and other tissues.
    Kidney Int. 1999 Mar;55(3):778-92 PMID: 10027916
  2. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.
    Nature. 2001 Apr 26;410(6832):1111-6 PMID: 11323676
  3. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
    Nat Genet. 2001 Dec;29(4):418-25 PMID: 11694875
  4. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
    Genes Dev. 2001 Dec 15;15(24):3243-8 PMID: 11751630
  5. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.
    Cancer Cell. 2004 Apr;5(4):375-87 PMID: 15093544
  6. Why do cancers have high aerobic glycolysis?
    Nat Rev Cancer. 2004 Nov;4(11):891-9 PMID: 15516961
  7. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.
    Cancer Cell. 2007 Jan;11(1):37-51 PMID: 17222789
  8. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.
    Br J Cancer. 2008 Oct 7;99(7):989-94 PMID: 18766181
  9. Lung cancer.
    N Engl J Med. 2008 Sep 25;359(13):1367-80 PMID: 18815398
  10. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
    Nat Med. 2008 Dec;14(12):1351-6 PMID: 19029981
  11. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.
    J Clin Invest. 2008 Dec;118(12):3930-42 PMID: 19033663
  12. Tumor suppressors and cell metabolism: a recipe for cancer growth.
    Genes Dev. 2009 Mar 1;23(5):537-48 PMID: 19270154
  13. Understanding the Warburg effect: the metabolic requirements of cell proliferation.
    Science. 2009 May 22;324(5930):1029-33 PMID: 19460998
  14. Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM).
    Mol Cancer. 2009 Jun 26;8:41 PMID: 19558692
  15. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase.
    Nat Protoc. 2009;4(7):1064-72 PMID: 19561589
  16. Primary tumor genotype is an important determinant in identification of lung cancer propagating cells.
    Cell Stem Cell. 2010 Jul 2;7(1):127-33 PMID: 20621056
  17. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice.
    Dis Model Mech. 2010 Sep-Oct;3(9-10):525-34 PMID: 20713647
  18. Regulation of cancer cell metabolism.
    Nat Rev Cancer. 2011 Feb;11(2):85-95 PMID: 21258394
  19. Metabolite profiles and the risk of developing diabetes.
    Nat Med. 2011 Apr;17(4):448-53 PMID: 21423183
  20. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells.
    Proc Natl Acad Sci U S A. 2011 May 24;108(21):8674-9 PMID: 21555572
  21. Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo.
    J Mol Med (Berl). 2011 Nov;89(11):1137-48 PMID: 21769686
  22. METabolic adaptations in the tumor MYCroenvironment.
    Cell Metab. 2012 Feb 8;15(2):131-3 PMID: 22326214
  23. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.
    Cell Metab. 2012 Feb 8;15(2):157-70 PMID: 22326218
  24. Metabolism of [U-13 C]glucose in human brain tumors in vivo.
    NMR Biomed. 2012 Nov;25(11):1234-44 PMID: 22419606
  25. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.
    Cell. 2012 Apr 27;149(3):656-70 PMID: 22541435
  26. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.
    Cell Metab. 2012 Jun 6;15(6):827-37 PMID: 22682223
  27. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth.
    Cancer Biol Ther. 2012 Oct;13(12):1185-94 PMID: 22892846
  28. Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor.
    Prostate. 2013 Aug;73(11):1171-81 PMID: 23532911
  29. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.
    Nature. 2013 May 30;497(7451):633-7 PMID: 23665962
  30. Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance.
    Cell Cycle. 2013 Jul 1;12(13):1987-8 PMID: 23759579
  31. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies.
    Clin Chem. 2013 Nov;59(11):1657-67 PMID: 23897902
  32. Glutamine and cancer: cell biology, physiology, and clinical opportunities.
    J Clin Invest. 2013 Sep;123(9):3678-84 PMID: 23999442
  33. Exploiting the bad eating habits of Ras-driven cancers.
    Genes Dev. 2013 Oct 1;27(19):2065-71 PMID: 24115766
  34. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.
    Cell. 2013 Oct 10;155(2):397-409 PMID: 24120138
  35. Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose.
    Nat Med. 2014 Jan;20(1):93-7 PMID: 24317119
  36. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.
    Mol Cancer Ther. 2014 Apr;13(4):890-901 PMID: 24523301
  37. Age- and diet-associated metabolome remodeling characterizes the aging process driven by damage accumulation.
    Elife. 2014 Apr 29;3:e02077 PMID: 24843015
  38. Rapid modelling of cooperating genetic events in cancer through somatic genome editing.
    Nature. 2014 Dec 18;516(7531):428-31 PMID: 25337879
  39. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA.
    Cell Metab. 2015 Jan 6;21(1):81-94 PMID: 25565207
  40. In vivo analysis of lung cancer metabolism: nothing like the real thing.
    J Clin Invest. 2015 Feb;125(2):495-7 PMID: 25607834
  41. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation.
    J Clin Invest. 2015 Feb;125(2):687-98 PMID: 25607840
  42. Famine versus feast: understanding the metabolism of tumors in vivo.
    Trends Biochem Sci. 2015 Mar;40(3):130-40 PMID: 25639751
  43. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.
    Cancer Res. 2015 Feb 1;75(3):544-53 PMID: 25644265
  44. Metabolic Heterogeneity in Human Lung Tumors.
    Cell. 2016 Feb 11;164(4):681-94 PMID: 26853473
  45. Intermediary metabolism of the lung.
    Environ Health Perspect. 1984 Apr;55:149-58 PMID: 6376097
  46. Increased glucose transport in ras-transformed fibroblasts: a possible role for N-glycosylation of GLUT1.
    FEBS Lett. 1997 May 5;407(3):267-70 PMID: 9175865
Article Info
Journal
Cell metabolism
Abbr.
Cell Metab
ISSN
1932-7420
Published
2016-03-08
Epub
2016-00-04
Pages
517-28
Language
English
Region
United States
NLM ID
101233170
PMCID
PMC4785096
Subset
IM
Grants
NIGMS NIH HHS · T32 GM007287 · United States
NCI NIH HHS · R01 CA168653 · United States
NCI NIH HHS · P30 CA014051 · United States
NIGMS NIH HHS · T32 GM007753 · United States
NCI NIH HHS · P30CA1405141 · United States
NCI NIH HHS · R01CA168653 · United States
NIGMS NIH HHS · T32GM007287 · United States
NHLBI NIH HHS · K08 HL119355 · United States
NIGMS NIH HHS · T32GM007753 · United States
NHLBI NIH HHS · K08HL119355 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com